ACE2 and hypertensive disorder: A distinct caveat in hypertension therapy in such patients shows that coronaviruses can bind to cells via ACE2, which means that patients who receive therapy with drugs of pharmacological origin that rise ACE2 levels may be put in jeopardy (65).